Indication Landscape (Non-generic products): Marketed & R&D (PI to Filed)

 
  Product Generic Name Company Launch WWLaunch WW Launch USLaunch US USA Indication Status (Current) Launch EuropeLaunch Europe Europe Indication Status (Current) Launch JapanLaunch Japan Japan Indication Status (Current) China Indication Status (Current) RoW Indication Status (Current)
General biliary disorders
  Marketed Orphacol cholic acid Laboratoires C.T.R.S. 04/07/2013 - - 04/07/2013 Marketed - - - -
  Compound Dantong Capsules herbal extract Tianyin Pharmaceutical 30/06/2010 - - - - - - Marketed -
  Pankreaplex Mono curcuma xanthorizza extract Schaper & Brümmer - - - - - - - - Marketed
 
  Approved Xebam cholic acid Asklepion Pharmaceuticals 30/06/2015 - Filed 30/06/2015 Approved - - - Phase III
  Xebam cholic acid Retrophin 30/06/2015 - Filed 30/06/2015 Approved - - - Phase III